These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8146208)

  • 1. von Willebrand's disease and hemophilia are associated with diminished thromboxane A2 (TXA2) formation in clotting whole blood.
    Beitz A; Müller G; Beitz J; Giessler C
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jan; 50(1):49-52. PubMed ID: 8146208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia, von Willebrand's disease, and related conditions: a spectrum of laboratory and clinical disorders.
    Edson JR
    Hum Pathol; 1970 Sep; 1(3):387-98. PubMed ID: 5315694
    [No Abstract]   [Full Text] [Related]  

  • 3. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transaminase levels in patients with hemophilia or von Willebrand's disease].
    Celada A; Ortega F; Magallón M; Martín-Villar J
    Sangre (Barc); 1984; 29(6):965-72. PubMed ID: 6335927
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of temperature on blood coagulation in vitro (author's transl)].
    Dreher A; Sutor AH
    Blut; 1978 Apr; 36(4):231-8. PubMed ID: 306264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
    Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
    Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced tissue factor (thromboplastin) activity in von Willebrand's disease.
    Zacharski LR; Rosenstein R; Cornwell GG; Davis WM; McIntyre OR
    Am J Med; 1974 Jul; 57(1):102-7. PubMed ID: 4546024
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.
    Weiss HJ; Turitto VT; Baumgartner HR
    J Lab Clin Med; 1978 Nov; 92(5):750-64. PubMed ID: 309498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged bleeding times with factor IX and XI deficiency von Willebrand's syndromes.
    Brody JI
    Am J Med Sci; 1975; 269(1):19-24. PubMed ID: 1079405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion.
    Turitto VT; Weiss HJ; Baumgartner HR
    J Clin Invest; 1984 Nov; 74(5):1730-41. PubMed ID: 6334102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The capillary thrombometer revisited.
    Kadota RP; Bowie EJ; Emslander HC; Fass DN; Ilstrup DM
    Haemostasis; 1987; 17(1-2):25-31. PubMed ID: 3496257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin on platelet aggregation and bleeding time in haemophilia and von Willebrand's disease.
    Praga C; Cortellaro M
    Acta Med Scand Suppl; 1971; 525():219-21. PubMed ID: 5317107
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple test for measuring platelet aggregation. Results in von Willebrand's disease and uraemia.
    Holdrinet A; Ewals M; Haanen C
    Thromb Diath Haemorrh; 1969 Aug; 22(1):174-91. PubMed ID: 4186076
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.